A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and ... Research highlights media misrepresentation of COVID-19 drug efficacy.

A new class of drugs could prevent resistant COVID-19 variants, study finds. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2023 / 03 / 230308171657.htm ...

Interest in the anti-parasitic drug ivermectin skyrocketed during the covid-19 pandemic, but evidence for many of its ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Stratified analyses revealed a notable increase in risk among cancer survivors aged 50 years or older at baseline (aHR, 1.85) ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which could set the stage for the company’s combination COVID-19/influenza shot.